Loading
companiesCompany
AngioDynamics
AngioDynamics makes the NanoKnife irreversible electroporation system, which destroys pancreatic and prostate tumours with electrical pulses rather than heat, plus microwave and radiofrequency ablation probes and vascular access ports used in chemotherapy.
Overview
AngioDynamics, founded in 1988 in upstate New York, is a mid-sized interventional device company. Its NanoKnife delivers microsecond high-voltage pulses between needle electrodes to kill tumour cells without heating, sparing vessels and ducts, and is used in locally advanced pancreatic cancer, liver tumours near vessels and, since a 2024 US clearance for prostate tissue ablation, in prostate cancer. It also sells the Solero microwave and StarBurst radiofrequency ablation systems, the Auryon laser atherectomy device and BioFlo ports and catheters used for chemotherapy access. OnCo links it to irreversible electroporation and microwave and radiofrequency ablation.
Similar pages
- TechnologyCryoablation systems
Shares Microwave and radiofrequency ablation systems, Irreversible electroporation (NanoKnife), Thermal ablation (RFA, microwave, cryo), Prostate cancer and the tag machines-wave.
- CompanyMedtronic
Shares Microwave and radiofrequency ablation systems, Thermal ablation (RFA, microwave, cryo) and the tag machines-wave.
- CompanyViewRay (MRIdian)
Shares Hepatocellular carcinoma, Pancreatic ductal adenocarcinoma, Prostate cancer and the tag machines-wave.
- CompanyIceCure Medical
Shares Thermal ablation (RFA, microwave, cryo) and the tag machines-wave.
- TechnologyPhoton-counting CT
Shares Hepatocellular carcinoma, Pancreatic ductal adenocarcinoma and the tag machines-wave.
- TechnologyElastography and contrast-enhanced ultrasound
Shares Hepatocellular carcinoma, Pancreatic ductal adenocarcinoma, Prostate cancer and the tag machines-wave.
- TechnologyCarbon-ion synchrotrons and facilities
Shares Hepatocellular carcinoma, Pancreatic ductal adenocarcinoma, Prostate cancer and the tag machines-wave.
- TechnologyCyberKnife robotic radiosurgery
Shares Hepatocellular carcinoma, Pancreatic ductal adenocarcinoma, Prostate cancer and the tag machines-wave.
cancers
fronts
technologies
trials
A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic CancerCOLDFIRE-III Trial: Efficacy of Irreversible Electroporation and Stereotactic Body Radiotherapy for Perivascular and Peribiliary Colorectal Liver MetastasesDose Finding, Efficacy and Immunological Response of IP-001 Following MWA or IRE for CRLM